Industry News
Patients With Diabetes, Cancer To Benefit From Slow-Release 'Jelly' Delivery System
Jan 30, 2013
Duke University biomedical engineers have developed a new delivery system that overcomes the shortcomings of a promising class of peptide drugs - very small proteins - for treating diseases such as diabetes and cancer. There are more than 40 peptide drugs approved for use in humans and more than 650 are being tested in clinical studies... Read More
Deep-Fried Food Associated With An Increased Risk Of Prostate Cancer And Frequent, Regular Consumption Has Strongest Effect
Jan 30, 2013
Regular consumption of deep-fried foods such as French fries, fried chicken and doughnuts is associated with an increased risk of prostate cancer, and the effect appears to be slightly stronger with regard to more aggressive forms of the disease, according to a study by investigators at Fred Hutchinson Cancer Research Center. Corresponding author Janet L. Stanford, Ph.D... Read More
More Nurses Needed To Cope With UK's Biggest Cancer Killer
Jan 29, 2013
There are not enough specialist nurses to cope with the demands of the UK's biggest cancer killer, according to a new report. More than 40,000 people are diagnosed with lung cancer every year with fewer than one in 10 likely to survive beyond five years. However, despite the poor outcomes for the disease, experts fear that specialist nurse posts may be cut as part of NHS cutbacks... Read More
Vitesse™ Brachytherapy Treatment Planning Software Receives FDA 510(k) Clearance
Jan 29, 2013
Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse™ real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided b... Read More
News From The Journal Of Clinical Investigation: Jan. 25, 2013
Jan 29, 2013
Green tea and Vardenafil: a killer chemotherapy combo Several recent studies have demonstrated that EGCG, a major constituent of green tea, has anti-cancer properties, but the molecular mechanisms underlying its effects are unknown... Read More
DNA- Repairing Protein May Be Key To Preventing Recurrence Of Some Cancers
Jan 29, 2013
Just as the body can become resistant to antibiotics, certain methods of killing cancer tumors can end up creating resistant tumor cells. But a University of Central Florida professor has found a protein present in several types of cancer, including breast and ovarian cancer, which could be helpful in preventing tumors from coming back... Read More
Singapore Scientists Led By A*STAR's Genome Institute Of Singapore Identify Four Distinct Mechanisms That Contribute To Gastric Cancers
Jan 29, 2013
Scientists at the Genome Institute of Singapore (GIS) headed a study which culminated in the discovery of four processes by which gastric cancer is formed. With gastric cancer being the second most common cause of cancer deaths worldwide (almost 750,000 deaths annually) and also an Asian disease, this poses as an extremely important find... Read More
Elderly People With Advanced Bowel Cancer Do Just As Well As Younger People When Treated With Avastin® (Bevacizumab) With Chemotherapy
Jan 29, 2013
First randomized study prospectively evaluating Avastin in combination with chemotherapy specifically in elderly patients with advanced bowel cancer shows it can significantly stall disease more than chemotherapy alone Just a month after a leading charity warned that ageism in the NHS is stopping older cancer patients getting better treatments1 and the Health Secretary pledged... Read More
News From The Journal Of Clinical Investigation: Jan. 25, 2013
Jan 29, 2013
Green tea and Vardenafil: a killer chemotherapy combo Several recent studies have demonstrated that EGCG, a major constituent of green tea, has anti-cancer properties, but the molecular mechanisms underlying its effects are unknown... Read More
More Nurses Needed To Cope With UK's Biggest Cancer Killer
Jan 29, 2013
There are not enough specialist nurses to cope with the demands of the UK's biggest cancer killer, according to a new report. More than 40,000 people are diagnosed with lung cancer every year with fewer than one in 10 likely to survive beyond five years. However, despite the poor outcomes for the disease, experts fear that specialist nurse posts may be cut as part of NHS cutbacks... Read More
Previous Page Next Page